AI Assistant
Blog
Pricing
Log In
Sign Up
DOP028. Efficacy and safety of retreatment with vedolizumab in patients with ulcerative colitis
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.